Research and development of protein-based therapeutics
Affibody has a broad pipeline with the most advanced projects in clinical studies. The pipeline is designed to demonstrate the value and versatility of the Affibody® technology.
Affibodys latest Press releases
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q2 (August 23, 2018)